4.05
2.41%
-0.10
Trevi Therapeutics Inc (TRVI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
33.28%
11.91
|
8.933 | 9.045 | 8.382 | 7.563 |
Interest Income/Expense |
75.00%
0.001
|
0.004 | 0.003 | 0.153 | 0.231 |
Operating Income/Loss |
33.28%
-11.91
|
-8.933 | -9.045 | -8.382 | -7.563 |
Nonoperating Income/Loss |
11.86%
0.996
|
1.13 | 1.334 | 1.207 | 1.155 |
Income/Loss From Continuing Operations Before Tax |
39.82%
-10.91
|
-7.803 | -7.711 | -7.175 | -6.408 |
Income Tax Expense/Benefit |
144.44%
-0.008
|
0.018 | -0.013 | -0.03 | -0.007 |
Income/Loss From Continuing Operations After Tax |
39.39%
-10.90
|
-7.821 | -7.698 | -7.145 | -6.401 |
Net Income/Loss
|
39.39%
-10.90
|
-7.821 | -7.698 | -7.145 | -6.401 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
65,161%
99.52
|
0.1525 | 99.33 | 98.70 | 98.61 |
Diluted Average Shares |
65,161%
99.52
|
0.1525 | 99.33 | 98.70 | 98.61 |
Basic Earnings Per Share |
37.50%
-0.11
|
-0.08 | -0.08 | -0.07 | -0.06 |
Diluted Earnings Per Share |
37.50%
-0.11
|
-0.08 | -0.08 | -0.07 | -0.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):